Target intelligence / Profile preview

mir-99a-let-7c cluster host gene (MIR99AHG)

Target
MIR99AHG
Molecular classification
Long noncoding RNA (lncRNA), Non-coding RNA, miRNA host gene
01

Overview

MIR99AHG (mir-99a-let-7c cluster host gene) is a long noncoding RNA that acts as the host gene for the microRNA cluster miR-99a/let-7c/miR-125b2[1][4][5]. It is implicated in several regulatory processes, especially in cancer biology, where it can function as either a tumor suppressor (e.g., in lung adenocarcinoma by promoting autophagy and suppressing proliferation and metastasis) or a pro-metastatic factor (e.g., in colorectal cancer via alternative splicing). MIR99AHG exerts its effects through both its lncRNA transcript (interacting with proteins like ANXA2 and PTBP1 to modulate autophagy and splicing) and its encoded miRNAs that regulate key targets such as mTOR[2][3][5]. In immune response, its altered expression affects macrophage polarization and inflammation in the context of tuberculosis[1]. MIR99AHG and its associated miRNAs are frequently downregulated in cancers (often due to chromosomal deletions), and their expression correlates with patient prognosis, suggesting utility as biomarkers. While currently there are no direct drugs or safety concerns identified, MIR99AHG represents a potential therapeutic and diagnostic target, particularly for tumors with known dysregulation of this pathway[4][5].

Other names
MONCDILA1Megakaryocytic oncogenic non-coding RNACyclin D1-interacting long noncoding RNA 1C21orf34C21orf35LINC00478Long intergenic non-protein coding RNA 478
02

Mechanism of action

Potentially, modulation of gene expression via microRNA cluster activity Regulation of downstream targets (e.g., mTOR signaling, alternative splicing of SMARCA1 via PTBP1)

03

Biological functions

Host for miR-99a/let-7c/miR-125b2 clusterRegulation of cell proliferationRegulation of metastasisPromotion of autophagyRegulation of alternative splicingModulation of inflammatory response
04

Disease associations

Cancer (e.g., lung adenocarcinoma, colorectal cancer, acute megakaryoblastic leukemia, gastric cancer, breast cancer, endometrial cancer)Infection (Mycobacterium tuberculosis infection)Pulmonary fibrosis
05

Biomarkers

Expression level of MIR99AHG for survival prediction in lung adenocarcinoma and colorectal cancerSMARCA1-L isoform (splicing biomarker in colorectal cancer)

Beyond the preview

Go deeper on mir-99a-let-7c cluster host gene (MIR99AHG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mir-99a-let-7c cluster host gene (MIR99AHG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call